NPPA and cardiac hypertrophy: Treatment with GSL synthesis inhibitor D-PDMP prevented cardiac hypertrophy in mice fed a high-fat, high-cholesterol diet and reduced the expression of BNP and ANP, biomarkers of cardiac hypertrophy.